3 Top Cybersecurity Stocks to Buy in May
When it comes to cybersecurity, I don't know much about how it works from an experiential perspective. So, I suppose one could say I'm an outsider. But even an outsider like me understands that businesses must invest in cybersecurity in 2025. And I can appreciate that the need for cybersecurity will only get bigger in the coming years.
Research firm Gartner predicts that spending for cybersecurity will increase by 15% in 2025 alone, which is huge when looking at an entire market. Gartner further predicts that the cybersecurity threat will increasingly come from generative artificial intelligence (AI) applications, highlighting how the threat evolves over time. Cybersecurity companies, consequently, must be fast-changing as well.
When it comes to the future of cybersecurity, I believe that CrowdStrike (NASDAQ: CRWD), Rubrik (NYSE: RBRK), and Palo Alto Networks (NASDAQ: PANW) are three cybersecurity stocks that investors should consider here in May. Here's why.
1. CrowdStrike: The top dog
When it comes to cloud-based cybersecurity, CrowdStrike is routinely recognized as a top player in the space. The company provides a subscription platform for its products, providing it with recurring revenue. It completed its fiscal 2025 on Jan. 31. And it ended the year with annualized recurring revenue (ARR) of $4.2 billion, which was up 23% from the end of fiscal 2024.
CrowdStrike's Falcon platform isn't a single cybersecurity product but is composed of 29 separate software modules that customers can use to meet their needs. The company is currently modifying its business model with this. Before, customers would select what they wanted and pay the subscription price. Now, customers can agree to a certain level of spending and use it on the module they want.
It's called Falcon Flex, and the hope is that this will lower the bar when it comes to experimentation with CrowdStrike's modules. As customers try new modules for the first time, the hope is that they'll see the value and use them regularly. In other words, CrowdStrike plans to boost growth by making it easier for existing customers to adopt more software modules, which sounds like a good idea to me.
As of the end of its fiscal 2025, only 21% of CrowdStrike's customers used eight or more of its software modules. Getting its customers to use more modules is quite significant for its long-term growth. The recent launch of Falcon Flex could help it get there, and it's one reason I like CrowdStrike stock today.
2. Rubrik: The niche up-and-comer
Many investors know about CrowdStrike, but far fewer have heard about Rubrik. That's understandable. It only went public about 13 months ago, so it's a new company for most investors. Moreover, with $887 million in trailing-12-month revenue, it's considerably smaller than other publicly traded cybersecurity companies.
Whereas CrowdStrike tries to prevent attacks, Rubrik gives customers a secure way to prepare for an attack beforehand and get back to normal after it happens. The reality is that even if cybersecurity players stop most attacks, they don't stop all of them. And the risk of one getting through might only increase with advances in AI.
The good thing about Rubrik's focus on this aspect of the market is that it's not a direct competitor with CrowdStrike or others -- in fact, it partners with CrowdStrike. This gives the up-and-coming company its own little corner of the market, and it's growing fast. Like CrowdStrike, Rubrik's fiscal 2025 ended on Jan. 31. It ended fiscal 2025 with an ARR of just over $1 billion, which was up a strong 39%.
Investors should consider Rubrik stock now, not only because it's fast-growing. The company also just started generating positive free cash flow. This profitability metric suggests that management can scale its business while maintaining operational excellence. This combination could soon start elevating the attention it receives from the investment community.
3. Palo Alto Networks: The relentless consolidator
Rubrik is a niche player, but even CrowdStrike could be considered niche compared to how broad Palo Alto Networks is with its vision. It has both hardware and software solutions. Its software products can be used on the cloud or on-premises. It's a large portfolio of products that have been both built and acquired over many years, which makes it one of the best cybersecurity stocks for investors interested in covering all the bases.
Indeed, Palo Alto Networks is always eager to acquire another business -- it already acquired one in 2025 by buying Protect AI for $700 million. While there are risks to being a company that makes a lot of acquisitions, the company has historically done it well, and it is paying off with growth. For example, it just completed its fiscal third quarter of 2025, showing good growth in its newer products.
Specifically, Palo Alto Networks grew its ARR for Next-Generation Security by 34% year over year to over $5 billion. And demand for its products overall is promising. In Q3, its remaining performance obligations (its future revenue under contract) grew by 19% to a whopping $13.5 billion. In short, the outlook for this company is as strong as ever, making Palo Alto Networks another cybersecurity stock to consider here in May.
In closing, the subject of valuation for these companies is also important, but that's a completely different subject from the things that I've discussed here. But allow me to say that the valuation for Rubrik stock is far lower than that for CrowdStrike stock, and it's comparable to the valuation for Palo Alto Networks. But I believe that Rubrik, being a smaller company, has a chance for a better growth rate from here.
Rubrik is probably the riskiest of these three stocks, given its size and newcomer status. But for investors willing to take a shot with a less-proven player, Rubrik might be the best value for long-term investors.
Should you invest $1,000 in CrowdStrike right now?
Before you buy stock in CrowdStrike, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and CrowdStrike wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $639,271!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $804,688!*
Now, it's worth noting Stock Advisor 's total average return is957% — a market-crushing outperformance compared to167%for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor.
See the 10 stocks »
*Stock Advisor returns as of May 19, 2025
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Globe and Mail
20 minutes ago
- Globe and Mail
Insider Buying and Options Surge Spark Bullish Interest in UnitedHealth (UNH)
UnitedHealth Group (UNH) is drawing attention from traders after a spike in call option activity and notable insider buying. Despite the stock being down nearly 40% year-to-date, a weaker-than-expected Q1 earnings report, and a softer outlook, recent activity suggests growing confidence in a potential recovery. Confident Investing Starts Here: Heightened Activity Signals Bullish Sentiment On Thursday, more than 162,000 call options were traded on UNH. That's a 29% jump compared to the stock's typical daily call volume of around 126,000. This level of activity often reflects bullish expectations from traders anticipating upward price movement. Insiders are also showing conviction. On May 14, Director John H. Noseworthy purchased 300 shares at an average price of $312.16. Six days later, CEO Stephen Hemsley bought 86,700 shares at an average of $288.57 per share, totaling over $25 million. In total, insiders have acquired 109,408 shares over the past 90 days, worth approximately $31.6 million. Insider buying of this scale often signals confidence in long-term value. Institutional investors have also been increasing their exposure to these assets. Vanguard, Wellington Management, and Norges Bank all added to their positions last quarter. Institutional ownership now stands at 87.9%, highlighting continued support from long-term holders. Stock Rebounds Slightly as Fundamentals Show Mixed Signals The stock closed Friday at $303.22, up 2.49% on the day. It remains far below its 52-week high of $630.73 and just above the recent low of $248.88. At current levels, UNH has a market cap of about $275 billion, a P/E ratio of 14.11, and a dividend yield of 2.84%. The company recently raised its quarterly dividend to $2.21 per share. UnitedHealth posted Q1 revenue of $109.6 billion, slightly below consensus estimates. Earnings per share came in at $7.20, missing expectations of $7.29. While analysts still expect full-year EPS of $29.54, several firms have lowered their price targets in response to the softer results and rising sector concerns. Options market data reinforces the bullish tilt. The put/call ratio is 0.48, indicating more call buying than put buying. This ratio suggests traders are positioning for a potential rebound in the near term. In summary, while UnitedHealth continues to face pressure from weaker earnings and macroeconomic headwinds, the surge in call option activity, insider buying, and strong institutional support indicate renewed investor interest. Is UNH a Good Stock to Buy Right Now? According to The Street's analysts, UnitedHealth is a Moderate Buy. The average UNH price target is $369.73, implying a 21.93% upside. See more UNH analyst ratings Disclaimer & Disclosure Report an Issue
Globe and Mail
20 minutes ago
- Globe and Mail
Oxford Properties and CT REIT Announce Major Retrofit at Canada Square, Anchored by New 20-year Office Lease with Canadian Tire Corporation
TORONTO , June 9, 2025 /CNW/ - Oxford Properties Group ("Oxford"), the global real estate arm of OMERS, and CT Real Estate Investment Trust ("CT REIT") (TSX: today announced, in partnership with Canadian Tire Corporation ("CTC") (TSX: CTC) (TSX: CTC.A), a transformative investment to retrofit the existing office buildings at Canada Square, a key midtown Toronto hub. This Canadian-led partnership includes a 550,000 square foot, 20-year office lease with CTC, demonstrating the enduring appeal of centrally located, transit-connected workplaces and representing a major investment in Toronto's urban core. The redevelopment project represents a combined investment of over $200 million by Canada Square co-owners Oxford and CT REIT. The two office towers at 2180 and 2200 Yonge Street will be retrofitted to deliver 680,000 square feet of highly functional and modernized office space, over 80% of which will be anchored by CTC. Having operated its head office at Canada Square for over 50 years, CTC is also investing to build a next-generation headquarters for thousands of employees. "This is a proud milestone for Canadian Tire and a major reinvestment in a neighbourhood we've called home for more than half a century," said Greg Hicks , President and CEO, Canadian Tire Corporation . "We're excited to help transform this vibrant corner of the city. Our employees will be among the thousands who come here each day – for work, for play and for the ease of new transit connections in every direction." Originally constructed in the 1960s and 1970s, the 18-storey building at 2180 Yonge Street will undergo internal upgrades and a complete façade renewal, followed by a full renovation of the 17-storey tower at 2200 Yonge Street. Construction, which will begin in late 2025, will minimize embodied carbon from the project while introducing significant energy efficiency upgrades in support of LEED Certification. The retrofit work will also deliver new employee amenities and approximately 15,000 square feet of modern retail space on Yonge Street, significantly improve the streetscape and offer a refreshed retail experience for the neighbourhood. "This 'made in Canada ' solution which sees the coming together of these great Canadian institutions to revitalize a key hub for Torontonians is a proud moment for OMERS and Oxford ," said Blake Hutcheson , President and CEO of OMERS . "This investment represents our ongoing commitment to being a champion for Canada , here at home and around the world. We are proud to put our pensioners' dollars to work to improve our cities while, at the same time, delivering on our obligation to generate returns to pay pensions for our members." The project will further benefit the community by delivering an upgraded and more accessible TTC entrance on Yonge Street to help local residents and workers more efficiently access Eglinton station. "Canada Square is a crown-jewel property and a generational asset, and this first step in its redevelopment allows us to begin to unlock its full potential," said Kevin Salsberg , President and CEO, CT REIT . "This major reinvestment exemplifies our commitment to enhancing our assets and providing reliable, durable and growing results for our unitholders. We're building for today while setting the stage for the decades to come." "This substantial investment at Canada Square is part of Oxford's deep conviction that well-located, high-quality, and sustainable workplaces that focus on the employee experience will continue to outperform," said Daniel Fournier , Executive Chair at Oxford Properties . "A company of Canadian Tire's stature signing a multi-decade office lease speaks to the trust our customers have in Oxford to create their ideal workplace. Not only is this an environmentally friendly approach to revitalizing one of the most transit-connected sites in the city, but it brings a substantial amount of employment to the neighbourhood and will benefit Torontonians for generations to come as we continue to advance our long-term plans for Canada Square." The office retrofit project is an important step towards the planned redevelopment of the 9.2-acre site into a vibrant, mixed-use addition to the community. Oxford and CT REIT continue to advance plans for the west side of the site that contemplate a significant amount of critically needed new rental housing and public open space in one of the city's most transit-connected nodes. FORWARD-LOOKING INFORMATION This press release contains statements that may constitute "forward-looking statements" within the meaning of applicable securities laws, which reflect the current expectations of CTC and/or CT REIT management regarding future events and financial commitments concerning Canada Square. All statements, other than statements of historical fact, contained in this press release that address activities, events or developments that CTC and/or CT REIT or a third-party expects or anticipates will or may occur in the future, including with respect to the redevelopment of Canada Square and the assumptions underlying the same, are forward-looking statements. Readers are cautioned that such information may not be appropriate for other purposes. Although CTC and CT REIT management believe that the forward-looking statements in this press release are based on information, estimates and assumptions that are reasonable, such statements are necessarily subject to a number of risks, uncertainties and other factors that could cause actual actions and results to differ materially from those expressed or implied in such forward-looking statements. For more information on the material risks, uncertainties, factors and assumptions that could cause actual actions and results to differ materially from current expectations, refer to section 14.0 (Forward-Looking Information and Other Investor Communication) of CTC's 2025 First Quarter Management's Discussion and Analysis and all subsections therein, available on the SEDAR+ website at and and section 5 (Risk Factors) of CT REIT's Annual Information Form for fiscal 2024, and sections 12.0 (Enterprise Risk Management) and 14.0 (Forward-looking Information) of CT REIT's Management's Discussion and Analysis for Q1 2025 and fiscal 2024, as well as CT REIT's other public filings, all of which are available at and at CTC and CT REIT do not undertake to update any forward-looking statements, whether written or oral, that may be made from time to time by either of them or on their behalf, to reflect new information, future events or otherwise, except as required by applicable securities laws. ABOUT OXFORD PROPERTIES GROUP Oxford Properties Group ("Oxford") is a leading global real estate investor, developer and manager. Established in 1960, Oxford and its portfolio companies manage approximately C$80 billion of assets across four continents on behalf of their investment partners. Oxford's owned portfolio encompasses logistics, office, retail, multifamily residential, life sciences, credit and hotels in global gateway cities and high-growth hubs. A thematic investor with a committed source of capital, Oxford invests in properties, portfolios, development sites, debt, securities and real estate businesses across the risk-reward spectrum. Together with its portfolio companies, Oxford is one of the world's most active developers with over 70 projects currently underway globally across all major asset classes. Oxford is owned by OMERS, the Canadian defined benefit pension plan for Ontario's municipal employees. Learn more here. ABOUT CT REAL ESTATE INVESTMENT TRUST CT Real Estate Investment Trust ("CT REIT") is an unincorporated, closed-end real estate investment trust formed to own income-producing commercial properties located primarily in Canada . Its portfolio is comprised of over 375 properties totaling more than 31 million square feet of GLA, consisting primarily of net lease single-tenant retail properties across Canada . Canadian Tire Corporation, Limited, is CT REIT's most significant tenant. For more information, visit ABOUT CANADIAN TIRE CORPORATION Canadian Tire Corporation, Limited (TSX: CTC.A, TSX: CTC, "CTC") has been a proudly Canadian business since 1922. Guided by its brand purpose, "We are here to make life in Canada better," CTC has built an expansive national retail presence, exceptional customer brand trust and one of Canada's strongest workforces – employing, along with its local Dealers and franchisees, tens of thousands of Canadians. At its core are retail businesses, each designed to serve life's pursuits: Canadian Tire, offering products spanning Living, Playing, Fixing, Automotive, and Seasonal & Gardening, bolstered by notable banners Party City and PartSource; Mark's, a leading source for casual and industrial wear; SportChek, Hockey Experts, Sports Experts and Atmosphere, offering the best brands of active wear and gear; and Pro Hockey Life, a hockey specialty store catering to elite players. CTC's banners, brand partners and credit card offerings are unified through its Triangle Rewards loyalty program – a linchpin of CTC's customer-driven strategy. With nearly 12 million members, Triangle integrates first-party data to deliver valuable rewards and personalized experiences across nearly 1,700 retail and gasoline outlets. CTC also operates a retail petroleum business and a Financial Services business and holds a majority interest in CT REIT, a TSX-listed Canadian real estate investment trust. For more information, visit SOURCE Canadian Tire Corporation, Limited
Globe and Mail
20 minutes ago
- Globe and Mail
Microbot Medical Continues to Strengthen Commercial Capabilities in Preparation for the anticipated Q3 2025 Launch of its LIBERTY® Endovascular Robotic System
HINGHAM, Mass., June 09, 2025 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), developer of the innovative LIBERTY Endovascular Robotic System, today announced the continued expansion of its commercial team in preparation for the anticipated U.S. launch of the LIBERTY System, which is projected during the third quarter of 2025. The Company remains actively engaged with the U.S. Food and Drug Administration (FDA), with a 510(k) decision now expected during the third quarter of this year. This updated FDA decision timeline remains within the FDA's original scheduled review window and is not expected to affect the Company's planned launch upon clearance. 'Our recent interactions with the FDA have been productive, and we remain confident in the process and outcome,' said Harel Gadot, Chairman, CEO & President. 'We continue to operate with full momentum and position the Company for an anticipated launch during the third quarter of this year, which includes the continued build out of our commercial infrastructure and preparing the organization to deliver on our strategy.' As part of the Company's ongoing launch preparation, it recently expanded its commercial team with the addition of Michael Lytle as the head of Sales Operations & Analytics. Mr. Lytle brings deep experience in sales support, data analysis, and operational excellence. He is expected to play a key role in shaping market intelligence tools and processes to optimize the sales cycle and drive strategic growth. Prior to joining Microbot, Mr. Lytle held increasing leadership roles at ZOLL Cardiac Management Solutions (CMS), a division of ZOLL Medical Corporation, where he supported the rollout of innovative cardiac care technologies. 'We believe that Michael's addition will strengthen our launch readiness plans, and that his expertise will help us target the right markets, allocate resources effectively, and accelerate commercial execution,' concluded Mr. Gadot. The LIBERTY System is currently under FDA review, is not available for sales in the US, and clearance is not guaranteed. About Microbot Medical Microbot Medical Inc. (NASDAQ: MBOT) is a pre-commercial stage medical technology company with a vision to redefine endovascular robotics and improve the quality of care for millions of patients and providers globally. The Company has developed the world's first single-use, fully disposable endovascular robotic system, which aims to eliminate traditional barriers to accessing advanced robotic systems. Further information about Microbot Medical® is available at Safe Harbor Statements to future financial and/or operating results, future growth in research, technology, clinical development, commercialization and potential opportunities for Microbot Medical Inc. and its subsidiaries, along with other statements about the future expectations, beliefs, goals, plans, or prospects expressed by management, constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 and the Federal securities laws. Any statements that are not historical fact (including, but not limited to statements that contain words such as 'will,' 'believes,' 'plans,' 'anticipates,' 'expects' and 'estimates') should also be considered to be forward-looking statements. Forward-looking statements involve risks and uncertainties, including, without limitation, the Company's need for and ability to obtain additional working capital to continue its transition to a commercially focused company, market conditions, risks inherent in the development and/or commercialization of the LIBERTY® Endovascular Robotic System, uncertainty in the results of regulatory pathways and regulatory approvals, including whether the FDA will timely grant 510(k) clearance to commercially market the LIBERTY® Endovascular Robotic System in the United States if at all, uncertainty resulting from political, social and geopolitical conditions, particularly any changes in personnel or processes or procedures at the FDA and announcements of tariffs on imports into the U.S., disruptions resulting from new and ongoing hostilities between Israel and the Palestinians and other neighboring countries, and maintenance of intellectual property rights. Additional information on risks facing Microbot Medical® can be found under the heading 'Risk Factors' in Microbot Medical's periodic reports filed with the Securities and Exchange Commission (SEC), which are available on the SEC's web site at Microbot Medical® disclaims any intent or obligation to update these forward-looking statements, except as required by law
